BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Topics » Medical devices » Digital health

Digital health
Digital health RSS Feed RSS

Other news to note for Sept. 9, 2020

Sep. 9, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambu, Analog Devices, A.R.C. Laser, Avricore Health, Benchmark Electronics, Change Healthcare, Clearside Biomedical, Coracoid Solutions, Coremap, D&D Pharmatech, Dnanudge, Evonetix, Fotona, Genova Diagnostics, Gogomeds, Hospitec, Joint Commission, Kit Check, Lifelabs, Livongo, Lncbio, Magellan Health, Medline Industries, Nanostring, Nanox, Orexo, Paradise Genomics, Parvizi Surgical Innovation, Personal Genome Diagnostics, Pharmigene, Regenexbio, Respiration, Rocky Mountain Analytical, S2 Genomics, Sca Pharma, Scrum, Spi Medical, Sqi Diagnostics, Thermo Fisher Scientific, Thrive Health, Thunderbio Science, Trendbio, Vizient.
Read More

In the clinic for Sept. 9, 2020

Sep. 9, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alydia Health, BD, Dreamed Diabetes, Sight Sciences.
Read More
Approved stamp

Cureapp wins approval for Cureapp SC, Japan’s first therapeutic app

Sep. 4, 2020
By Gina Lee
HONG KONG – Tokyo-based Cureapp Inc. has received the Ministry of Health, Labour and Welfare (MHLW)’s green light to manufacture and sell Cureapp SC [Smoking Cessation] Nicotine Addiction Treatment App and CO Checker, its therapeutics app to aid patients who are quitting smoking.
Read More
Mobiledetect Bio BCC19 test kit

Detectachem wins EUA for rapid COVID-19 test kit

Sep. 3, 2020
By Mary Ellen Schneider
Detectachem Inc. has scored an emergency use authorization (EUA) from the U.S. FDA to market a new molecular RNA test kit for SARS-CoV-2 that provides color-coded results in about 30 minutes.
Read More
Software and sensor

Biofourmis raises $100M to expand digital care footprint

Sep. 3, 2020
By Meg Bryant
Biofourmis Inc. scooped up $100 million in a series C round that was led by Softbank Vision Fund 2. The funds are earmarked to accelerate U.S. and global expansion of Biofourmis’ artificial intelligence (AI)-powered health analytics platform and to advance its pipeline of digital therapeutics. The company focuses software-based therapeutics and AI tools for personal predictive care and has U.S. FDA-cleared products that aim to boost clinicians’ ability to remotely monitor and treat patients.
Read More

Other news to note for Sept. 3, 2020

Sep. 3, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Acarix, Access Biologicals, Aditx Therapeutics, Caredfor, Castlight Health, Centogene, Deep Longevity, Fivebase, Fulgent Genetics, Gateway Foundation, Guardian Research Network, Henry Schein, Impulse Dynamics, Indemic, Intermountain Healthcare, Lumithera, MDclone, Mcmaster Healthlabs, Oncocyte, Regent Pacific, Safeology, Speedx, Verto Health, Viz.ai, Salveo Diagnostics, Zyris.
Read More

Regulatory front for Sept. 2, 2020

Sep. 2, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: BloodPAC, Refocus Group.
Read More
Thermalpass image

Health Canada licenses Thermalpass fever-detection system for COVID-19

Sep. 1, 2020
By David Godkin
TORONTO – Its Canadian medical device establishment licence now firmly in hand, Toronto-based Internet of Things Inc. (ITT) is set to launch a fever-detection system for identifying possible COVID-19 carriers at the entrances of airports, long term care facilities, schools and other places where people congregate. The Thermalpass is an AI-enabled, deep learning screening system that got its start as a road-related weather sensing system, today detecting elevated body temperature.
Read More

Regulatory actions for Sept. 1, 2020

Sep. 1, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ctl Amedica, Medtronic, Roche, T2 Biosystems, Transmed7.
Read More
Black and white arrows merging into one

Generex establishes joint venture with Worldwide Digitech

Aug. 28, 2020
By Annette Boyle
Generex Biotechnology Corp.’s wholly owned subsidiary Nugenerex Health partnered with Worldwide Digitech (WWDT) LLC to create a 50/50 joint venture, Nugenhealth LLC. The new company will draw on WWDT’s software to develop an end-to-end software-as-a-service (SaaS) solution for chronic care management using remote patient monitoring.
Read More
Previous 1 2 … 94 95 96 97 98 99 100 101 102 … 135 136 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing